See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← XAR page
XStocksXray
Market X-Ray report · 23 October 2026

Xaar plc (XAR)

London Exchange · UK · prices in GBX · close of 23 Oct 2026

Key indicators

Last closeGBX 155.00
52-week range96.33 – 165.00
Return, 1 month / 3 months+19.2% / +27.6%
Return, 1 year / 3 years+31.4% / −13.9%
TrendUptrend
RSI (14)63
Volatility (1 year)45.8%
Worst drawdown (1 year)-26.6%
Average daily value traded15.33M GBX
Dividend yield–

Market X-Ray price-based

70/ 100 · High confidence · ahead of 85% of stocks on this exchange
Trend83
Momentum78
Stability (higher is calmer)44
Liquidity77
Income–

Five-year price chart navy: price · brown: 200-day average

46.161061662262862021-102023-012024-042025-072026-10

About the company

Xaar plc is a British technology company that designs and makes industrial inkjet printheads and the associated systems that drive them. Its printheads are used by machine builders and manufacturers for decorating ceramic tiles, printing packaging and labels, and adding graphics or functional coatings to products. The company is based in Cambridge, England, and supplies equipment makers and industrial printers in markets around the world.

The shares are listed on the London Exchange in UK under the code XAR, and the price on this page is in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Xaar plc (XAR) trades on the London Exchange in UK. It last closed at GBX 155.00 on 23 October 2026.

Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 563 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 31.4% and over the last three months it rose 27.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Xaar plc (XAR)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend83 · StrongTrading above its long-term averages and near its highs.
Above 200-day average23.7%
From 52-week high-3.4%
Momentum78 · StrongRising faster than most stocks on this exchange.
3-month return27.6%
6-month return19.2%
12-month return, skipping the last month10.2%
Stability (higher is calmer)44 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.8%
Worst drawdown, 1 year (smaller is calmer)-26.6%
Liquidity77 · StrongTrades actively.
Average daily value traded15.33M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−1.3%
1 month+19.2%
3 months+27.6%
6 months+19.2%
1 year+31.4%
3 years−13.9%
5 years−10.3%

Signals

50-day / 200-day average133.70 / 125.34
Golden / death cross (60 days)Golden, 29 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)7.63

Technical summary

DailyStrongly bullish12 bullish · 4 neutral · 0 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026